Skip Nav Destination
Issues
15 December 2006
-
Cover Image
Cover Image
Anti-Ki67 (red) and anti-RNASEN (green) double staining of esophageal cancer tissue. RNASEN is expressed mainly in the cytoplasm of most of the esophageal cancer cells including the Ki67 positive proliferating cells. Cancers with high RNASEN expression had poor prognosis. Please see Sugito et al. on page 7322 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editorial
The Biology Behind
CCR Practice of Translational Oncology
Molecular Pathways
CCR Focus
Report from FDA
Perspective
Human Cancer Biology
β2-Microglobulin Promotes the Growth of Human Renal Cell Carcinoma through the Activation of the Protein Kinase A, Cyclic AMP–Responsive Element-Binding Protein, and Vascular Endothelial Growth Factor Axis
Takeo Nomura; Wen-Chin Huang; Haiyen E. Zhau; Daqing Wu; Zhihui Xie; Hiromitsu Mimata; Majd Zayzafoon; Andrew N. Young; Fray F. Marshall; M. Neale Weitzmann; Leland W.K. Chung
Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy Volunteers
Chris A. Learn; Peter E. Fecci; Robert J. Schmittling; Weihua Xie; Isaac Karikari; Duane A. Mitchell; Gary E. Archer; ZhengZheng Wei; Holly Dressman; John H. Sampson
Imaging, Diagnosis, Prognosis
Cancer Therapy: Clinical
Contribution of ABL Kinase Domain Mutations to Imatinib Resistance in Different Subsets of Philadelphia-Positive Patients: By the GIMEMA Working Party on Chronic Myeloid Leukemia
Simona Soverini; Sabrina Colarossi; Alessandra Gnani; Gianantonio Rosti; Fausto Castagnetti; Angela Poerio; Ilaria Iacobucci; Marilina Amabile; Elisabetta Abruzzese; Ester Orlandi; Franca Radaelli; Fabrizio Ciccone; Mario Tiribelli; Roberto di Lorenzo; Clementina Caracciolo; Barbara Izzo; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; Giovanni Martinelli; on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia
Immunologic and Clinical Effects of Injecting Mature Peptide-Loaded Dendritic Cells by Intralymphatic and Intranodal Routes in Metastatic Melanoma Patients
Thierry Lesimple; Eve-Marie Neidhard; Virginie Vignard; Claudia Lefeuvre; Henri Adamski; Nathalie Labarrière; André Carsin; Delphine Monnier; Brigitte Collet; Gilles Clapisson; Brigitte Birebent; Irène Philip; Louis Toujas; Mohamed Chokri; Véronique Quillien
A Neoadjuvant/Adjuvant Randomized Trial of Colorectal Cancer Patients Vaccinated with an Anti-Idiotypic Antibody, 105AD7, Mimicking CD55
Gustav J. Ullenhag; Ian Spendlove; Nicholas F.S. Watson; Adrian A. Indar; Mukul Dube; Richard A. Robins; Charles Maxwell-Armstrong; John H. Scholefield; Lindy G. Durrant
HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan
Shigehisa Kitano; Shinichi Kageyama; Yasuhiro Nagata; Yoshihiro Miyahara; Atsunori Hiasa; Hiroaki Naota; Satoshi Okumura; Hiroshi Imai; Taizo Shiraishi; Masahiro Masuya; Masakatsu Nishikawa; Junzo Sunamoto; Kazunari Akiyoshi; Takashi Kanematsu; Andrew M. Scott; Roger Murphy; Eric W. Hoffman; Lloyd J. Old; Hiroshi Shiku
Phase I, Pharmacokinetic, and Biological Study of Erlotinib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors
Amita Patnaik; Debra Wood; Anthony W. Tolcher; Marta Hamilton; Jeffrey I. Kreisberg; Lisa A. Hammond; Garry Schwartz; Muralidhar Beeram; Manuel Hidalgo; Monica M. Mita; Julie Wolf; Paul Nadler; Eric K. Rowinsky
Cancer Therapy: Preclinical
Enhancement of Immunologic Tumor Regression by Intratumoral Administration of Dendritic Cells in Combination with Cryoablative Tumor Pretreatment and Bacillus Calmette-Guerin Cell Wall Skeleton Stimulation
Masaru Udagawa; Chie Kudo-Saito; Go Hasegawa; Kazuhito Yano; Aiko Yamamoto; Masae Yaguchi; Masahiro Toda; Ichiro Azuma; Takehisa Iwai; Yutaka Kawakami
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds